COVID-19 outcomes in patients with rheumatoid arthritis with biologic or targeted synthetic DMARDs

Objectives We aimed to investigate the role of rheumatoid arthritis (RA) with biologic or targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARD) exposure in COVID-19 outcomes.Methods Our study retrieved data from the US Collaborative Network in TriNetX between 1 January 2018 and 31 Dec...

Full description

Bibliographic Details
Main Authors: James Cheng-Chung Wei, Jih-Jin Tsai, Li-Teh Liu, Chun-Hong Chen, Liang-Jen Chen, Shiow-Ing Wang
Format: Article
Language:English
Published: BMJ Publishing Group 2023-07-01
Series:RMD Open
Online Access:https://rmdopen.bmj.com/content/9/3/e003038.full